^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Tarlox (tarloxotinib bromide)

    i
    Company:
    Molecular Templates, Pathos, Proacta, Signpath Pharma
    Drug class:
    EGFR inhibitor
    Related drugs:
    Apply
    NSCLC Exon 20 or HER2-activating Mutations (RAIN) (NCT03743350)
    Phase 2
    Rain Therapeutics, inc
    Not yet recruiting
    Last update posted :
    11/16/2018
    Initiation :
    02/01/2019
    Primary completion :
    01/01/2021
    Completion :
    01/01/2021
    EGFR • HER-2
    |
    EGFR mutation • HER-2 mutation • EGFR exon 20 insertion • EGFR exon 20 mutation
    |
    Tarlox (tarloxotinib bromide)